Cargando…
A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
OBJECTIVES: Venous thromboembolism (VTE) is a common worldwide disease. The burden of multimorbidity, that is, two or more chronic diseases, has increased. Whether multimorbidity is associated with VTE risk remains to be studied. Our aim was to determine any association between multimorbidity and VT...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277039/ https://www.ncbi.nlm.nih.gov/pubmed/37328186 http://dx.doi.org/10.1136/bmjopen-2023-072934 |
_version_ | 1785060206433009664 |
---|---|
author | Ahrén, Jonatan Pirouzifard, MirNabi Holmquist, Björn Sundquist, Jan Halling, Anders Sundquist, Kristina Zöller, Bengt |
author_facet | Ahrén, Jonatan Pirouzifard, MirNabi Holmquist, Björn Sundquist, Jan Halling, Anders Sundquist, Kristina Zöller, Bengt |
author_sort | Ahrén, Jonatan |
collection | PubMed |
description | OBJECTIVES: Venous thromboembolism (VTE) is a common worldwide disease. The burden of multimorbidity, that is, two or more chronic diseases, has increased. Whether multimorbidity is associated with VTE risk remains to be studied. Our aim was to determine any association between multimorbidity and VTE and any possible shared familial susceptibility. DESIGN: A nationwide extended cross-sectional hypothesis - generating family study between 1997 and 2015. SETTING: The Swedish Multigeneration Register, the National Patient Register, the Total Population Register and the Swedish cause of death register were linked. PARTICIPANTS: 2 694 442 unique individuals were analysed for VTE and multimorbidity. MAIN OUTCOMES AND MEASURES: Multimorbidity was determined by a counting method using 45 non-communicable diseases. Multimorbidity was defined by the occurrence of ≥2 diseases. A multimorbidity score was constructed defined by 0, 1, 2, 3, 4 or 5 or more diseases. RESULTS: Sixteen percent (n=440 742) of the study population was multimorbid. Of the multimorbid patients, 58% were females. There was an association between multimorbidity and VTE. The adjusted odds ratio (OR) for VTE in individuals with multimorbidity (2 ≥ diagnoses) was 3.16 (95% CI: 3.06 to 3.27) compared with individuals without multimorbidity. There was an association between number of diseases and VTE. The adjusted OR was 1.94 (95% CI: 1.86 to 2.02) for one disease, 2.93 (95% CI: 2.80 to 3.08) for two diseases, 4.07 (95% CI: 3.85 to 4.31) for three diseases, 5.46 (95% CI: 5.10 to 5.85) for four diseases and 9.08 (95% CI: 8.56 to 9.64) for 5 ≥ diseases. The association between multimorbidity and VTE was stronger in males OR 3.45 (3.29 to 3.62) than in females OR 2.91 (2.77 to 3.04). There were significant but mostly weak familial associations between multimorbidity in relatives and VTE. CONCLUSIONS: Increasing multimorbidity exhibits a strong and increasing association with VTE. Familial associations suggest a weak shared familial susceptibility. The association between multimorbidity and VTE suggests that future cohort studies where multimorbidity is used to predict VTE might be worthwhile. |
format | Online Article Text |
id | pubmed-10277039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-102770392023-06-19 A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism Ahrén, Jonatan Pirouzifard, MirNabi Holmquist, Björn Sundquist, Jan Halling, Anders Sundquist, Kristina Zöller, Bengt BMJ Open Cardiovascular Medicine OBJECTIVES: Venous thromboembolism (VTE) is a common worldwide disease. The burden of multimorbidity, that is, two or more chronic diseases, has increased. Whether multimorbidity is associated with VTE risk remains to be studied. Our aim was to determine any association between multimorbidity and VTE and any possible shared familial susceptibility. DESIGN: A nationwide extended cross-sectional hypothesis - generating family study between 1997 and 2015. SETTING: The Swedish Multigeneration Register, the National Patient Register, the Total Population Register and the Swedish cause of death register were linked. PARTICIPANTS: 2 694 442 unique individuals were analysed for VTE and multimorbidity. MAIN OUTCOMES AND MEASURES: Multimorbidity was determined by a counting method using 45 non-communicable diseases. Multimorbidity was defined by the occurrence of ≥2 diseases. A multimorbidity score was constructed defined by 0, 1, 2, 3, 4 or 5 or more diseases. RESULTS: Sixteen percent (n=440 742) of the study population was multimorbid. Of the multimorbid patients, 58% were females. There was an association between multimorbidity and VTE. The adjusted odds ratio (OR) for VTE in individuals with multimorbidity (2 ≥ diagnoses) was 3.16 (95% CI: 3.06 to 3.27) compared with individuals without multimorbidity. There was an association between number of diseases and VTE. The adjusted OR was 1.94 (95% CI: 1.86 to 2.02) for one disease, 2.93 (95% CI: 2.80 to 3.08) for two diseases, 4.07 (95% CI: 3.85 to 4.31) for three diseases, 5.46 (95% CI: 5.10 to 5.85) for four diseases and 9.08 (95% CI: 8.56 to 9.64) for 5 ≥ diseases. The association between multimorbidity and VTE was stronger in males OR 3.45 (3.29 to 3.62) than in females OR 2.91 (2.77 to 3.04). There were significant but mostly weak familial associations between multimorbidity in relatives and VTE. CONCLUSIONS: Increasing multimorbidity exhibits a strong and increasing association with VTE. Familial associations suggest a weak shared familial susceptibility. The association between multimorbidity and VTE suggests that future cohort studies where multimorbidity is used to predict VTE might be worthwhile. BMJ Publishing Group 2023-06-16 /pmc/articles/PMC10277039/ /pubmed/37328186 http://dx.doi.org/10.1136/bmjopen-2023-072934 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Cardiovascular Medicine Ahrén, Jonatan Pirouzifard, MirNabi Holmquist, Björn Sundquist, Jan Halling, Anders Sundquist, Kristina Zöller, Bengt A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
title | A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
title_full | A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
title_fullStr | A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
title_full_unstemmed | A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
title_short | A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
title_sort | hypothesis - generating swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277039/ https://www.ncbi.nlm.nih.gov/pubmed/37328186 http://dx.doi.org/10.1136/bmjopen-2023-072934 |
work_keys_str_mv | AT ahrenjonatan ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT pirouzifardmirnabi ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT holmquistbjorn ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT sundquistjan ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT hallinganders ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT sundquistkristina ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT zollerbengt ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT ahrenjonatan hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT pirouzifardmirnabi hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT holmquistbjorn hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT sundquistjan hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT hallinganders hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT sundquistkristina hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism AT zollerbengt hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism |